A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Neoplasms
Interventions: DRUG: PF-03084014|DRUG: PF-03084014|DRUG: PF-03084014
Sponsor: Pfizer